PRCT Stock Risk & Deep Value Analysis
Procept Biorobotics Corp
Healthcare • Medical Devices
DVR Score
out of 10
The Bottom Line on PRCT
We analyzed Procept Biorobotics Corp using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran PRCT through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.
📈PRCT Performance Overview3yr weekly
Unlock PRCT Performance Chart
See 3 years of price history, quarterly revenue trends, and DVR score changes
Weekly adjusted close · Quarterly revenue & EPS · DVR score history
PRCT Stock Risk Analysis
Overall Risk
Moderate
Financial Risk
Medium
Market Risk
Medium
About Procept Biorobotics Corp (PRCT)
Sector
Healthcare
Industry
Medical Devices
Market Cap Category
small
Market Cap
$1.74B
PRCT Deep Value Analysis
PRCT Red Flags & Warning Signs
Premium- ⚠
Slower than expected adoption rates or competitive pressures in new markets
- ⚠
Potential regulatory hurdles or changes in reimbursement policies
- ⚠
Clinical trial setbacks or adverse safety profile concerns emerging
Unlock PRCT Red Flags & Risk Warnings
Premium members see every risk event we found.
Unlock the full report
Create a free account to see the DVR score, risk flags, and AI analysis.
Unlock everything for $47/yr
$79/yrSave 41%
- ✓ Catalysts, bull case, moat & red flags
- ✓ Unlimited stock analyses + alerts
- ✓ Full database, search & portfolio (50 stocks)
7-day money back · Cancel anytime
PRCT Financial Health Metrics
Market Cap
$1.74B
PRCT Competitive Moat Analysis
PremiumMoat Rating
Narrow
Moat Trend
Expanding
Moat Sources
2 Identified
The proprietary nature of its Aquablation technology, backed by extensive patents and robust clinical data, creates a significant barrier to entry. As more urologists and hospitals adopt the system, training and integration costs increase switching costs for these institutions, enhancing durability.
PRCT Competitive Moat Analysis
Premium unlocks moat rating, sources & durability.
PRCT Catalysts & Growth Drivers
Near-Term (0-6 months)
- •Q1 2026 Earnings Report (Estimated early May 2026)
- •Continued acceleration of Aquablation procedure volumes and system placements (monthly/quarterly updates)
- •Expansion of CPT/reimbursement codes in key US regions or private payers
Medium-Term (6-18 months)
- •Announcement of new international market entries (e.g., major European or Asian countries)
- •Strategic partnerships to accelerate distribution or expand market reach
- •Updated long-term clinical data readouts further solidifying Aquablation efficacy
Long-Term (18+ months)
- •Aquablation therapy becoming the standard of care for BPH across major markets
- •Potential for platform expansion into adjacent urological indications or other soft tissue applications
- •Achieving sustainable profitability and significant free cash flow generation
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
PRCT Bull Case: What Could Go Right
- ✓
Continued acceleration in quarterly Aquablation procedure volumes and system placements
- ✓
Positive updates on reimbursement expansion and international market penetration
- ✓
Improvement in gross margins and trajectory towards positive free cash flow
Bull Case Analysis
See what could go right with Premium
Never miss a move on PRCT
Create a free account to set price alerts and get notified on Telegram when PRCT hits your targets.
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.
FAQ
What is the DVR Score for Procept Biorobotics Corp (PRCT)?
As of March 17, 2026, Procept Biorobotics Corp has a DVR Score of 8.8 out of 10, placing it in the "Hidden Gem" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What is the market capitalization of Procept Biorobotics Corp?
Procept Biorobotics Corp's market capitalization is approximately $1.7B. The company operates in the Healthcare sector within the Medical Devices industry.
What ticker symbol does Procept Biorobotics Corp use?
PRCT is the ticker symbol for Procept Biorobotics Corp. The company trades on the NGM.
What is the risk level for PRCT stock?
Our analysis rates Procept Biorobotics Corp's overall risk as Moderate. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
How often is the PRCT DVR analysis updated?
Our AI-powered analysis of Procept Biorobotics Corp is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on March 17, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.